Abstract:Propofol is frequently used for anesthesia in cancer surgery. It has been suggested that treatment with propofol serves a tumor-suppressing role in human gastric cancer (GC). Therefore, the present study aimed to explore the potential mechanism of propofol in GC. In the present study, GC cell lines (HGC-27 and AGS) were treated with various concentrations of propofol, and an MTT assay was performed to detect the cell viability. In addition, flow cytometry and Transwell assays were used to evaluate the apoptosis and invasive ability of GC cells, respectively. Western blotting was performed to detect the protein levels of cyclin-dependent kinase inhibitor P21 (P21), B-cell lymphoma-2 (Bcl-2), matrix metalloproteinase 9 (MMP9) and E26 oncogene homolog 1 (ETS1). Furthermore, reverse transcription-quantitative PCR was used to examine the expression levels of circular RNA-PVT1 (circ-PVT1), micoRNA-195-5p (miR-195-5p) and ETS1 in GC tissues and cells. The target interaction between miR-195-5p and circ-PVT1 or ETS1 was predicted through bioinformatics analysis, and verified by dual-luciferase reporter gene assay. In addition, a mouse xenograft model was established for in vivo experiments. It was identified that propofol inhibited the viability and invasion, but promoted apoptosis of HGC-27 and AGS cells in a dose-dependent manner. Propofol could inhibit Bcl-2 and MMP9 expression, and increase P21 expression in GC cells. The expression levels of circ-PVT1 and ETS1 were increased in GC tissues and cells, and miR-195-5p was decreased. Additionally, the treatment with propofol could lead to decreased circ-PVT1 expression in GC cells. These results could be reversed by ETS1 upregulation or miR-195-5p-knockdown in GC cells. Furthermore, circ-PVT1 could act as a miR-195-5p sponge to modulate ETS1 expression. Additionally, the effects of transfection with circ-PVT1 small interfering RNA (si-circ-PVT1) on HGC-27 and AGS cells could be reversed by treatment with miR-195-5p inhibitor. Meanwhile, miR-195-5p inhibitor reversed the si-circ-PVT1-induced low expression of ETS1. Downregulation of ETS1 induced by propofol in HGC-27 and AGS cells could be restored by circ-PVT1 upregulation or miR-195-5p silencing. Circ-PVT1 silencing facilitated the propofol-induced anti-GC effect in vivo. In conclusion, the present study indicated that propofol inhibited the proliferation and invasion, but enhanced the apoptosis of GC cells by regulating the circ-PVT1/miR-195-5p/ETS1 axis.

Propofol Suppresses Cell Progression by Inhibiting CCL18 Expression in Hepatoblastoma

Propofol Inhibits Proliferation, Migration, Invasion and Promotes Apoptosis Through Down-Regulating Mir-374A in Hepatocarcinoma Cell Lines

Propofol Exerts Anti-Hepatocellular Carcinoma by Microvesicle-Mediated Transfer of Mir-142-3p from Macrophage to Cancer Cells

Effects of Propofol on Colon Cancer Metastasis Through STAT3/HOTAIR Axis by Activating WIF‐1 and Suppressing Wnt Pathway

Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression.

Propofol Inhibits the Adhesion of Hepatocellular Carcinoma Cells by Upregulating Microrna-199A and Downregulating MMP-9 Expression.

Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway

The Effect of Propofol on the Proliferation and Apoptosis of Hepatocellular Carcinoma Cells Through TGF-Β1/Smad2 Signaling Pathway

Propofol suppresses non-small cell lung cancer progression by modulating circ_0001727/miR-516b-5p/LRRC1 axis

Propofol Disrupts Cell Carcinogenesis and Aerobic Glycolysis by Regulating Circtada2a/mir-455-3p/foxm1 Axis in Lung Cancer

Propofol Exerts Anticancer Activity on Hepatocellular Carcinoma Cells by Raising Lncrna DGCR5.

Propofol suppresses the growth and invasion of cervical carcinoma cells by inhibiting MIR155HG

Propofol Inhibits Breast Cancer Cells Proliferation and Migration by Down-Regulating TGFβ1/Smad2/MMP-9 Signal

Propofol regulates the progression of hepatocellular carcinoma via the POLR2L/TGF-β signaling pathway

Propofol Suppresses Gastric Cancer Tumorigenesis by Modulating the Circular RNA‑PVT1/miR‑195‑5p/E26 Oncogene Homolog 1 Axis

RETRACTED: Propofol Inhibits Proliferation, Migration and Invasion of Gastric Cancer Cells by Up-Regulating Microrna-195

Repurposing propofol for breast cancer therapy through promoting apoptosis and arresting cell cycle

The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the NF-κB/HIF-1α Signaling Pathway

Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8

Propofol suppresses colorectal cancer development by the circ-PABPN1/miR-638/SRSF1 axis

Propofol Inhibits Cancer Malignancy by Disturbing Glucose Metabolism Through Hypoxia-Inducible Factor-1Α and Pigment Epithelium-Derived Factor Modulation